SIG
CBIO

Sargent Investment Group’s Crescent Biopharma CBIO Stock Holding History

Sargent Investment Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$28.2K – 221
2024
Q2 		$28.2K Sell
1,000
-80
-7% -$8.32K 0.01% 218
2024
Q1 		$324K Buy
1,080
+500
+86% +$149K 0.07% 147
2023
Q4 		$137K Hold
580
– – 0.03% 200
2023
Q3 		$87K Sell
580
-500
-46% -$78.9K 0.02% 195
2023
Q2 		$188K Hold
1,080
– – 0.05% 186
2023
Q1 		$135K Buy
+1,080
New +$243K 0.04% 188

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return